These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6511787

  • 1. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase).
    Weller PF, Bach DS, Austen KF.
    J Biol Chem; 1984 Dec 25; 259(24):15100-5. PubMed ID: 6511787
    [Abstract] [Full Text] [Related]

  • 2. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.
    Weller PF, Goetzl EJ, Austen KF.
    Proc Natl Acad Sci U S A; 1980 Dec 25; 77(12):7440-3. PubMed ID: 6261258
    [Abstract] [Full Text] [Related]

  • 3. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals.
    Weller PF, Bach D, Austen KF.
    J Immunol; 1982 Mar 25; 128(3):1346-9. PubMed ID: 6173432
    [Abstract] [Full Text] [Related]

  • 4. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.
    Dvorak AM, Letourneau L, Login GR, Weller PF, Ackerman SJ.
    Blood; 1988 Jul 25; 72(1):150-8. PubMed ID: 2455566
    [Abstract] [Full Text] [Related]

  • 5. The Charcot-Leyden crystal protein revisited-A lysopalmitoylphospholipase and more.
    Weller PF, Wang H, Melo RCN.
    J Leukoc Biol; 2020 Jul 25; 108(1):105-112. PubMed ID: 32272499
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily.
    Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG.
    J Immunol; 1993 Jan 15; 150(2):456-68. PubMed ID: 8419478
    [Abstract] [Full Text] [Related]

  • 7. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion.
    Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR.
    J Biol Chem; 2002 Apr 26; 277(17):14859-68. PubMed ID: 11834744
    [Abstract] [Full Text] [Related]

  • 8. Human Eosinophil lysophospholipase.
    Weller PF.
    Methods Enzymol; 1988 Apr 26; 163():31-43. PubMed ID: 3070299
    [No Abstract] [Full Text] [Related]

  • 9. Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis.
    Ackerman SJ, Gleich GJ, Weller PF, Ottesen EA.
    J Immunol; 1981 Sep 26; 127(3):1093-8. PubMed ID: 7021674
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Crystallographic characterization of human eosinophil Charcot-Leyden crystals.
    Sieker LC, Turley S, Le Trong I, Stenkamp RE, Weller PF, Ackerman SJ.
    J Mol Biol; 1988 Nov 20; 204(2):489-91. PubMed ID: 3221396
    [No Abstract] [Full Text] [Related]

  • 14. Significance of Charcot Leyden crystals in liver cytology-A case report.
    Thakral D, Agarwal P, Saran RK, Saluja S.
    Diagn Cytopathol; 2015 May 20; 43(5):392-4. PubMed ID: 25350873
    [Abstract] [Full Text] [Related]

  • 15. Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide.
    Dvorak AM, MacGlashan DW, Warner JA, Letourneau L, Morgan ES, Lichtenstein LM, Ackerman SJ.
    Clin Exp Allergy; 1997 Apr 20; 27(4):452-74. PubMed ID: 9146940
    [Abstract] [Full Text] [Related]

  • 16. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils.
    Dvorak AM, Ackerman SJ.
    Lab Invest; 1989 Apr 20; 60(4):557-67. PubMed ID: 2709814
    [Abstract] [Full Text] [Related]

  • 17. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary epithelial neoplasm of the pancreas.
    Dvorak AM, Letourneau L, Weller PF, Ackerman SJ.
    Lab Invest; 1990 May 20; 62(5):608-15. PubMed ID: 2160563
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.
    Dvorak AM, Weller PF, Monahan-Earley RA, Letourneau L, Ackerman SJ.
    Lab Invest; 1990 May 20; 62(5):590-607. PubMed ID: 2160562
    [Abstract] [Full Text] [Related]

  • 20. Comparison of six mammalian lysophospholipases.
    Garsetti DE, Steiner MR, Holtsberg F, Ozgür LE, Egan RW, Clark MA.
    J Lipid Mediat; 1993 May 20; 6(1-3):223-32. PubMed ID: 8357983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.